CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Cabaletta Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.48+0.07 (+4.96%)
Close on Oct 19, 2026
- Market cap
- $223.72M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.37 (−48.07%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $223.72M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.06
- Dividend yield
- –
- Free cash flow yield
- -68.93%
Fundamentals
- Net income
- -$181.32M
- EPS, diluted
- -$2.10
- Free cash flow
- -$154.21M
- Book value per share
- $1.39
- Diluted shares
- 151M
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Operating income
-$185.52M
Net income
-$181.32M
EPS, diluted
–
Free cash flow
-$154.21M
Reported periodTrailing twelve months